FINWIRES · TerminalLIVE
FINWIRES

$AVTR

2 stories mentioning AVTRUpdated 40d ago

Every FINWIRES story that references AVTR, newest first.

Wire

Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says

Avantor's (AVTR) turnaround narrative merits a constructive view, but that should be balanced against the level of execution still needed, RBC Capital Markets said in a note emailed Friday.The firm said that while investor expectations and the shares' multiples "have reset," it does not consider consensus estimates and company targets fully de-risked, such as free cash flow guidance, which is an important metric.The company's outlook of $500 million to $550 million of free cash flow in 2026 "seems difficult to achieve" after $39 million, excluding restructuring costs, in Q1, the note said.Meanwhile, Avantor's management's focus on improving e-commerce and service levels, as well as branding, is an indication that it is "addressing the right concerns," RBC said."Early signals are encouraging, and the Q1 2026 earnings report was the first in a while not accompanied by downward estimate revisions," the note said.RBC resumed Avantor's coverage with a sector perform rating and a $9 price target.Price: $7.76, Change: $-0.19, Percent Change: -2.33%

$AVTR
Research

Research Alert: Avantor: Q1 Results Above Consensus Despite Challenging Operating Environment

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Shares of AVTR jumped in premarket trading as Q1 results topped estimates despite underlying weakness, with adjusted EPS of $0.17 beating consensus by $0.01 though down from $0.23 in the prior year. Net sales remained flat at $1,581.4M but organic revenue declined 4.1%, with both VWR Distribution & Services (-4.8%) and Bioscience & Medtech Products (-2.0%) experiencing organic declines. Management characterized VWR's performance as showing "stabilization" after prolonged weakness. The higher-margin Bioscience segment (23.8% adjusted operating margin vs VWR's 9.2%) demonstrated "improved execution" and represents a key focus for Revival transformation efforts, in our view. Profitability metrics showed significant compression, with adjusted EBITDA margin falling 310 basis points to 13.9%. Operating cash flow declined to $58.7M from $109.3M, indicating continued working capital pressures. AVTR reaffirmed full-year 2026 guidance, suggesting management confidence despite the challenging environment.

$AVTR

Track with the FINWIRES app suite